Breaks Categories: News

WednesdayAug 14, 2019 9:22 am

NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Posts Q2 2019 Financial Results

Endonovo Therapeutics (OTCQB: ENDV) on Tuesday posted the company’s financial and operating results for the second quarter. The company reported revenues for the three months ended June 30, 2019 of $62,729, a sharp increase compared to $12,854 for the same period last year. Gross profits for the second quarter were $33,156, as compared to $12,304 for the same period last year. Endonovo also provided an update on the PEMF assets it acquired from Rio Grande Neurosciences for $4.5 million in December 2017. “I am pleased to announce we have executed the business plan and strategy we implemented after acquiring the…

Continue Reading

TuesdayAug 13, 2019 1:34 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Prepares First Closing of BZRTH Acquisition; CEO to Call Special Shareholder Meeting

Sugarmade (OTCQB: SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, today announced that it is now prepared to complete the first closing of its BZRTH, LLC acquisition. As a major supplier to the hydroponic and hemp cultivation sectors, BZRTH produces more than $30 million in annual revenues. In addition, the company is in the process of organizing a special meeting of shareholders to elect new directors, including at least two independent directors with no “material relationship” to the company. “It is an exciting time for Sugarmade, especially as the California licensing and…

Continue Reading

TuesdayAug 13, 2019 11:40 am

NetworkNewsBreaks – CMG Holdings Group, Inc. (CMGO) Releases Q2 2019 Financial Results, Provides Shareholder Update

CMG Holdings Group (OTC: CMGO) today announced financial results for the second quarter of 2019 and provided a shareholder update from the company’s CEO, Glenn Laken. Among other highlights, the company reported total revenues of $1.06 million, an increase of 358% over $232K from the same period of 2018. The company attributes the increased revenues to effective execution and financial management. In addition, the company noted that its primary operating subsidiary XA closed a six-figure contract with a prominent clothing retailer. “Overall, we have returned XA to strong growth and sustained profitability, which management projected heading into this year. With…

Continue Reading

TuesdayAug 13, 2019 10:33 am

NetworkNewsBreaks – Marijuana Company of America Inc. (MCOA) Announces Progress, Revenue Generation at Joint Venture Oregon Hemp Farm

Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA) together with joint venture partner Global Hemp Group Inc. (CSE: GHG) ( OTC: GBHPF) ( FRANKFURT: GHG) today announced that their joint venture subsidiary, Covered Bridge Acres Ltd. (“CBA”), has started generating revenue through operations at its hemp farm in Scio, Oregon. According to the update, CBA generated $525,500 in its first year of operation through a combination of the sales of raw biomass, plantlets, CBD crude oil and CBD distillate produced from various processing test runs, as well as other farm operations. In its most recent transaction, CBA…

Continue Reading

TuesdayAug 13, 2019 9:59 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Recent Achievements as Part of Overall Expansion Strategy

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced its recent achievements as part of the company’s overall strategy to expand its clinical development programs and bring its lead drug candidate, Oncoprex(TM) immunogene therapy, to commercialization. Per the update, Genprex has published recent as well as historical achievements to its newly launched, interactive corporate timeline, which can be found on the company’s website. “Since Genprex’s IPO last year, we have made significant progress in many areas of the company, including progress toward expansion of our clinical programs and sponsored research, our manufacturing process development and scalability, and the growth…

Continue Reading

TuesdayAug 13, 2019 9:51 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Subsidiary Receives Health Canada Cannabis R&D License

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that Health Canada has issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 to its subsidiary, Lexaria CanPharm ULC. According to the update, the license, which carries a four-year term unless renewed, is effective immediately and will allow one of the country’s newest and most advanced formulation laboratories to conduct extensive investigatory work in THC and CBD delivery using optimized, proprietary formulations and techniques. The purpose-built laboratory is permitted at local and federal levels and fully outfitted to produce DehydraTECH(TM) infusions and includes two different…

Continue Reading

TuesdayAug 13, 2019 9:30 am

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expects Positive Q4 Results, Provides Guidance for Fiscal 2020

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) this morning announced its projected revenue for the fiscal fourth quarter ended June 30, 2019 and provided guidance for fiscal 2020. Per the update, the company anticipates net revenue of about $19 million and positive adjusted EBITDA for the fourth quarter 2019. Supreme Cannabis also expects sustained revenue growth during 2020 as its wholly owned subsidiary 7ACRES scales production, new and higher-margin products are introduced, and additional brands start producing material revenue. The company plans to release audited fourth quarter and annual results on September 17, 2019. “Our company has taken…

Continue Reading

MondayAug 12, 2019 1:54 pm

NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Releases Q2 2019 Financial Results, Provides Shareholder Update

INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its financial results for the second quarter ended June 30, 2019 and also provided a year-to-date business update. “This year we remained focused on advancing our pipeline,” INmune Bio CEO RJ Tesi, M.D., said in the news release. “More recently we announced we have begun planning a Phase II trial for INB03 after receiving positive preliminary data from its clinical Phase I study. This preliminary data has allowed us to move forward with the development of…

Continue Reading

MondayAug 12, 2019 1:16 pm

NetworkNewsBreaks – Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) City Cannabis Opens Two New Premier Cannabis Retail Locations in Cultured BC Market

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) this morning announced that British Columbia’s Liquor and Cannabis Regulation Branch has issued a Cannabis Retail Store license to City Cannabis Co’s 2317 Cambie Street location and its Comox Valley location on Vancouver Island. Wildflower recently acquired City Cannabis Co, which, with its third and fourth locations in the province, is at the forefront of the BC retail cannabis market. “City Cannabis Co’s experience and history of operations for over five years in the most cultured cannabis market in the world has allowed them to accumulate priceless data that has been used to…

Continue Reading

MondayAug 12, 2019 12:35 pm

NetworkNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters Definitive Agreement to Acquire Vertically Integrated Assets in Arizona

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced its entry into a definitive agreement for the acquisition of 100 percent of the membership units of a licensed medical marijuana business in the state of Arizona (“The Asset”). The Asset, according to the update, is licensed under the provisions of the Arizona Medical Marijuana Act and operates a dispensary in Phoenix, which has been operational since 2015 with proprietary branded products and wholesale operations, including an established distribution network serving more than…

Continue Reading